Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) COGS-to-Revenue : 0.35 (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Shanghai Xiao Fang Pharmaceutical Co COGS-to-Revenue?

Shanghai Xiao Fang Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥44.6 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥129.1 Mil.

Shanghai Xiao Fang Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.35.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 was 65.43%.

Shanghai Xiao Fang Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Shanghai Xiao Fang Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Xiao Fang Pharmaceutical Co COGS-to-Revenue Chart

Shanghai Xiao Fang Pharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.37

0.41

0.35

0.34

Shanghai Xiao Fang Pharmaceutical Co Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial										0.36	0.32	0.36	0.35	0.35

Shanghai Xiao Fang Pharmaceutical Co COGS-to-Revenue Calculation

Shanghai Xiao Fang Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	163.19	/	474.584
	=	0.34

Shanghai Xiao Fang Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	44.616	/	129.072
	=	0.35

Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shanghai Xiao Fang Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	44.616 / 129.072
	=	65.43 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shanghai Xiao Fang Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Xiao Fang Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Xiao Fang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Xiao Fang Pharmaceutical Co Ltd (SHSE:603207) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 777, Hongzhu Road, Fengxian District, Shanghai, CHN, 201411

Website

http://www.xf-pharma.com

Shanghai Xiao Fang Pharmaceutical Co Ltd is engaged in Research and development, production and sales of topical medicines.

Shanghai Xiao Fang Pharmaceutical Co Headlines

No Headlines